
Lifecore Biomedical Inc
NASDAQ:LFCR

Intrinsic Value
The intrinsic value of one
LFCR
stock under the Base Case scenario is
10.02
USD.
Compared to the current market price of 6.55 USD,
Lifecore Biomedical Inc
is
Undervalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Lifecore Biomedical Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Lifecore Biomedical Inc
Balance Sheet Decomposition
Lifecore Biomedical Inc
Current Assets | 81.9m |
Cash & Short-Term Investments | 9.5m |
Receivables | 30.3m |
Other Current Assets | 42.1m |
Non-Current Assets | 173.5m |
PP&E | 152.9m |
Intangibles | 18.1m |
Other Non-Current Assets | 2.6m |
Free Cash Flow Analysis
Lifecore Biomedical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Lifecore Biomedical Inc
Revenue
|
130.9m
USD
|
Cost of Revenue
|
-85.2m
USD
|
Gross Profit
|
45.6m
USD
|
Operating Expenses
|
-51.9m
USD
|
Operating Income
|
-6.3m
USD
|
Other Expenses
|
-10.1m
USD
|
Net Income
|
-16.4m
USD
|
LFCR Profitability Score
Profitability Due Diligence
Lifecore Biomedical Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Score
Lifecore Biomedical Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
LFCR Solvency Score
Solvency Due Diligence
Lifecore Biomedical Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Score
Lifecore Biomedical Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LFCR Price Targets Summary
Lifecore Biomedical Inc
According to Wall Street analysts, the average 1-year price target for
LFCR
is 8.67 USD
with a low forecast of 7.07 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for LFCR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LFCR
stock under the Base Case scenario is
10.02
USD.
Compared to the current market price of 6.55 USD,
Lifecore Biomedical Inc
is
Undervalued by 35%.